top of page

About BIGMEDX

Latasha Jordan is a global expansion strategist focused on helping MedTech and digital health leaders move from “market entry” to sustained adoption. Her work sits at the intersection of regulatory research, market readiness analysis, and execution alignment—translating complex global conditions into clear, sequenced expansion decisions. Through BIGMEDX, she advises leadership teams on where demand is structurally forming, what regulatory and operating conditions must be met, and how to prioritize markets with precision rather than pressure.

Latasha Jordan 

Founder | Global MedTech Strategist

Certified Global Business Professional (CGBP)

Globalization Requires Operating Alignment.

Global expansion has changed. Presence is no longer proof of progress—adoption is.
BIGMEDX is built on a disciplined framework that replaces reactive entry with strategic sequencing:

Signal → Readiness → Alignment → Scale

We start with the signal:

Demand shifts, policy direction, capital movement, and competitive inflections.


We validate readiness:

Regulatory feasibility, reimbursement reality, infrastructure capacity, and buyer maturity.


We align execution:

Clinical trust, localization, partners, and operational enablement.


Then—and only then—we scale with confidence.

Why BIGMEDX Exists

Too many companies expand reactively—following headlines, competitors, or investor pressure—only to discover the market wasn’t ready, the operating model wasn’t aligned, or adoption stalled after launch. BIGMEDX exists because intelligence must precede capital deployment. Growth is not a geography game—it’s a sequencing discipline. When markets are prioritized by readiness and execution is built for adoption, expansion becomes durable, repeatable, and defensible.

bottom of page